Categories AlphaGraphs, Analysis, Technology
ServiceNow likely to deliver another blowout quarter on Wednesday
ServiceNow (NYSE: NOW) is slated to report second-quarter financial results after the regular trading hours on Wednesday, July 24. Analysts expect the software-as-a-service cloud company to report earnings of 63 cents per share, compared to 49 cents per share it reported a year ago.
Revenues are projected to jump 32% to $832.37 million, helped by the robust demand for its enterprise products and high renewal rates. In the first quarter, the company boasted of a 98% renewal rate, suggesting high customer satisfaction in the products.
Wall Street loves the stock too. In the trailing 52 weeks, the stock has gained 53%, outperforming most of its peers, on the back of better-than-expected quarterly results. In the past five years, the stock has increased almost five times.
The Santa Clara, California-based firm has also benefitted from a large chunk of companies shifting their operations to cloud-based infrastructure, driving demand for its subscription products and solutions.
For the second quarter, the management expects adjusted subscription billings to grow 32-33% year-over-year.
Customers, contracts and deals
CEO John Donahoe had earlier said that ServiceNow is committed to expanding its customer base across 75% of the Fortune 500 companies. At the end of the last reported quarter, its customer base exceeded 5,400.
READ: Microsoft leads the enterprise SaaS industry, grows quickly
In the second quarter, the company continued to build on its profile by signing major partnerships and contracts, which further add confidence in the stock. It extended its partnership with Microsoft Corp. (NASDAQ: MSFT) to optimize its products and cloud capabilities, besides acquiring Israel-based Appsee, a mobile app analytics platform.
Separately, ServiceNow boasts of six federal customers with a total annual contract value of over $10 million.
The stock has a 12-month average price target of $295, which is at a 2.4% upside from Tuesday’s trading price.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on